Champions Oncology: Jumps on Q1 beat
13/09/2018 21:54
** Shares of cancer focused R&D firm CSBR.O up 23 pct at
$10.40 after the bell
** Co posts better-than-expected Q1 results urn:newsml:reuters.com:*:nPn3vD2VHa
** Q1 revenue $6.2 mln vs analysts' estimate of $5.6 mln;
adj EPS $0.05 vs est $0.01
** Reiterates forecast of at least 20 percent revenue growth
in fiscal 2019
** Stock up 119 pct YTD
(Reporting by Saumya Sibi Joseph in Bengaluru)
((saumya.joseph@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 80 6749 9379; Reuters Messaging:
saumya.joseph.thomsonreuters.com@reuters.net))